Telespirometry in Amyotrophic Lateral Sclerosis (ALS)

Status unconfirmed

Conditions studied: Amyotrophic Lateral Sclerosis

In brief

The investigators seek to validate Slow Vital Capacity (SVC) measurement in seated and supine positions using conventional and portable spirometry.

Key facts

Study ID

NCT05106569

Run by

State University of New York - Upstate Medical University

People needed

100

Starts

2021-04-28

Expected to finish

2024-12-30

Last updated by the study team

2023-06-13

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of ALS as Clinically Possible, Clinically Probable, Laboratory-supported Probable and Clinically Definite ALS
• 18 years old to 100 years old, English-speaking ALS subjects, male and female

You may not qualify if…

• Use of non-invasive ventilation more than 16 hours daily
• Non-English Speaker
• Psychosis or severe mental illness
• Use of high-dose sedating psychotropic medications determined to potentially interfere with task performance
• Infection Control issues and specific Pulmonary, Cardiac, Vascular contraindications as listed in the Standardization of Spirometry 2019 Update (Graham 2019)

Where it is running

• SUNY Upstate — Syracuse, New York, United States
• Atrium Health — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.